Inhibrx Biosciences, Inc.
INBX· Nasdaq
Inhibrx Biosciences, Inc.
- Last sale
- Oct 1, 2026 · -2.13%
- Market cap
- $1.45B
- 14.72M shares
- Filings
- 156
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,300,000 | reported | |
| FY 2024 | 2024-12-31 | $200,000 | reported | |
| FY 2023 | 2023-12-31 | $1,800,000 | reported |
Inhibrx Biosciences, Inc. · CIK 2007919 · Engraved from SEC EDGAR
